Back

Admission biomarkers may not have an association with cardiovascular involvement in Latin American patients with Multisystem Inflammatory Syndrome in Children (MIS-C)

Galindo-Hayashi, J. M.; Gonzalez-Moctezuma, K.; Tamez-Rivera, O.; Villarreal-Trevino, A. V.

2023-06-16 cardiovascular medicine
10.1101/2023.06.13.23291351 medRxiv
Show abstract

ObjectivesThe aim of the study is to determine if there is an association between altered biomarkers and cardiovascular involvement in Latin American patients with MIS-C. DesignThe researchers of this study conducted a retrospective cohort study. SettingSecondary care maternal unit hospital in Monterrey, NL, Mexico. ParticipantsAny register of a Latin-American pediatric patient with MIS-C within the database from March 2019 to February 2022. Primary and secondary outcome measuresCut, mean, odds ratio (OR), relative ratio (RR), 95% confidence interval (CI) and p values of inflammatory markers associated with cardiovascular affection in MIS-C. As a secondary outcome we measure being male as an independent risk factor. ResultsNone of the biomarkers and gender variables taken were significant (Table 1). O_TBL View this table: org.highwire.dtl.DTLVardef@1140c78org.highwire.dtl.DTLVardef@13eb581org.highwire.dtl.DTLVardef@1fe447corg.highwire.dtl.DTLVardef@426569org.highwire.dtl.DTLVardef@10fd4bb_HPS_FORMAT_FIGEXP M_TBL O_FLOATNOTable 1.C_FLOATNO C_TBL ConclusionsThe researchers analysis suggests there is no evidence of cause-effect association between admission biomarkers and the presence of cardiovascular affection in MIS-C. Remarkably, neutrophilia and ESR had a high odds ratio and a nearly significant p-value, which makes them ideal for further analysis with a bigger sample. Additionally, gender was included as a risk factor and was analyzed independently, nonetheless, it was not associated with a higher risk of presenting cardiovascular affection. Article summary Strengths and limitations of this studyO_LIFirst study measuring the association of a series of available and economical biomarkers with a higher incidence of cardiovascular involvement in MIS-C in a Latin-American population. C_LIO_LISet ground for further research regarding the current treatment of MIS-C C_LIO_LISample size non-representative. C_LIO_LISince this is an observational study we cant fully control confounding and bias (e.j. reporting bias) C_LI

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Cureus
67 papers in training set
Top 0.1%
19.0%
2
BMJ Open
554 papers in training set
Top 1%
15.0%
3
PLOS ONE
4510 papers in training set
Top 12%
15.0%
4
Frontiers in Pediatrics
29 papers in training set
Top 0.1%
14.7%
50% of probability mass above
5
Open Heart
19 papers in training set
Top 0.2%
5.0%
6
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
3.7%
7
Journal of Clinical Medicine
91 papers in training set
Top 2%
3.1%
8
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.4%
1.4%
9
The American Journal of Cardiology
15 papers in training set
Top 1%
1.3%
10
Medicine
30 papers in training set
Top 1%
1.3%
11
PLOS Global Public Health
293 papers in training set
Top 5%
1.1%
12
Journal of the American Heart Association
119 papers in training set
Top 3%
1.0%
13
International Journal of Environmental Research and Public Health
124 papers in training set
Top 5%
1.0%
14
Vaccine
189 papers in training set
Top 2%
0.9%
15
Pediatric Infectious Disease Journal
16 papers in training set
Top 0.2%
0.9%
16
BMC Infectious Diseases
118 papers in training set
Top 4%
0.9%
17
The Journal of Pediatrics
15 papers in training set
Top 0.5%
0.9%
18
Journal of Internal Medicine
12 papers in training set
Top 0.5%
0.8%
19
eBioMedicine
130 papers in training set
Top 3%
0.8%
20
PeerJ
261 papers in training set
Top 13%
0.8%
21
Journal of Medical Virology
137 papers in training set
Top 4%
0.8%
22
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 3%
0.8%
23
Journal of Family Medicine and Primary Care
10 papers in training set
Top 0.7%
0.7%
24
BMC Medical Genomics
36 papers in training set
Top 2%
0.7%
25
Frontiers in Pharmacology
100 papers in training set
Top 6%
0.5%